Barrington Research Downgrades Haemonetics (HAE) to Market Performl; Scaling Back
Tweet Send to a Friend
Barrington Research downgraded Haemonetics (NYSE: HAE) from Outperform to Market Perform.
Barrington analyst said, "We Are Scaling Back Our Rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barrington analyst said, "We Are Scaling Back Our Rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
